Innoviva Correlations

INVA Stock

USD 18.57 0.04 0.22%

The current 90-days correlation between Innoviva and Day One Biopharmaceuticals is 0.44 (i.e., Very weak diversification). The correlation of Innoviva is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Innoviva Correlation With Market

Weak diversification

The correlation between Innoviva and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Innoviva and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

Moving together with Innoviva Stock

0.65	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.73	KRYS	Krystal Biotech	Pair Corr
0.72	PDSB	PDS Biotechnology Corp	Pair Corr
0.81	ABOS	Acumen Pharmaceuticals	Pair Corr
0.61	ADAP	Adaptimmune Therapeutics	Pair Corr
0.83	AFMD	Affimed NV	Pair Corr
0.76	AGIO	Agios Pharm	Pair Corr
0.75	AMGN	Amgen Inc	Pair Corr
0.84	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.69	STOK	Stoke Therapeutics	Pair Corr
0.73	BDTX	Black Diamond Therap	Pair Corr
0.85	CRVS	Corvus Pharmaceuticals	Pair Corr
0.8	DAWN	Day One Biopharmaceu	Pair Corr
0.74	CVS	CVS Health Corp Aggressive Push	Pair Corr

Moving against Innoviva Stock

0.64	MLAB	Mesa Laboratories	Pair Corr
0.49	XFOR	X4 Pharmaceuticals	Pair Corr
0.48	CDXS	Codexis	Pair Corr
0.46	DNA	Ginkgo Bioworks Holdings Trending	Pair Corr
0.35	MNPR	Monopar Therapeutics Trending	Pair Corr

Related Correlations Analysis

	EFTR	PLX	PDSB	LIFE	ELEV	DAWN	MRTX	AMLX	TERN	APLS
EFTR		-0.46	0.43	0.0	-0.27	0.4	0.0	0.04	0.45	-0.26	EFTR
PLX	-0.46		-0.92	0.0	0.59	-0.88	0.0	-0.68	-0.85	0.5	PLX
PDSB	0.43	-0.92		0.0	-0.42	0.93	0.0	0.69	0.83	-0.51	PDSB
LIFE	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	LIFE
ELEV	-0.27	0.59	-0.42	0.0		-0.47	0.0	-0.35	-0.4	0.31	ELEV
DAWN	0.4	-0.88	0.93	0.0	-0.47		0.0	0.82	0.81	-0.4	DAWN
MRTX	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	MRTX
AMLX	0.04	-0.68	0.69	0.0	-0.35	0.82	0.0		0.67	-0.16	AMLX
TERN	0.45	-0.85	0.83	0.0	-0.4	0.81	0.0	0.67		-0.12	TERN
APLS	-0.26	0.5	-0.51	0.0	0.31	-0.4	0.0	-0.16	-0.12		APLS
	EFTR	PLX	PDSB	LIFE	ELEV	DAWN	MRTX	AMLX	TERN	APLS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DAWN	+ 0.93	PDSB
TERN	+ 0.83	PDSB
AMLX	+ 0.82	DAWN
TERN	+ 0.81	DAWN
AMLX	+ 0.69	PDSB
TERN	+ 0.67	AMLX

High negative correlations

PDSB	- 0.92	PLX
DAWN	- 0.88	PLX
TERN	- 0.85	PLX
AMLX	- 0.68	PLX
APLS	- 0.51	PDSB
DAWN	- 0.47	ELEV

Risk-Adjusted Indicators

There is a big difference between Innoviva Stock performing well and Innoviva Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Innoviva's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EFTR	7.57	(4.53)	0.00	4.75	0.00	0.00	8.70	(27.78)	88.91
PLX	2.82	1.24	0.42	7.07	1.81	(4.11)	7.61	(3.77)	21.66
PDSB	3.99	(0.99)	0.00	(1.00)	0.00	0.00	7.93	(10.12)	24.25
LIFE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ELEV	5.24	0.46	0.07	0.71	5.53	(6.27)	10.77	(8.62)	40.61
DAWN	1.81	(0.30)	0.00	(0.31)	0.00	0.00	3.92	(3.46)	11.05
MRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AMLX	4.26	(0.12)	0.00	(0.13)	0.00	0.00	8.37	(8.97)	33.56
TERN	3.14	(0.68)	0.00	(0.91)	0.00	0.00	5.17	(6.80)	26.61
APLS	2.56	0.18	0.04	0.30	3.85	(2.56)	4.63	(4.71)	27.73

Innoviva Corporate Management

Pavel CFA	Chief Officer	Profile
Patricia Drake	I Therapeutics	Profile
Marianne CPA	Chief Secretary	Profile
Stephen MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC